Jim Simons Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$83.14 - $145.99 $5.85 Million - $10.3 Million
70,400 New
70,400 $10.3 Million
Q3 2019

Nov 13, 2019
SELL
$37.38 - $49.47 $4.55 Million - $6.03 Million
-121,800 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$39.79 - $67.01 $4.63 Million - $7.8 Million
116,400 Added 2155.56%
121,800 $5.33 Million
Q1 2019

May 14, 2019
BUY
$34.52 - $53.29 $186,408 - $287,766
5,400 New
5,400 $278,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email